Botanix Pharmaceuticals Limited ( (AU:BOT) ) has shared an update.
Botanix Pharmaceuticals Ltd has announced the quotation of 3,990,099 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of February 27, 2025. This move is part of the company’s strategy to enhance its capital structure and potentially increase its market presence, which could have implications for its stakeholders and industry positioning.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Ltd operates in the pharmaceutical industry, focusing on the development and commercialization of dermatology and antimicrobial products. The company is dedicated to leveraging its proprietary drug delivery technology to address unmet needs in the market.
YTD Price Performance: 7.95%
Average Trading Volume: 5,954,681
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$867.2M
For a thorough assessment of BOT stock, go to TipRanks’ Stock Analysis page.